← Leaderboards
Jing Chen
University Of Chicago
$12,817,541
Attributed
$12,817,541
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,817,541 · 5
By mechanism
R01$12,817,541 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Anita S. Chong$25,087,826
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionTumor GrowthCellsCell ProliferationCancer CellEnzymesIn VivoMetabolicPhosphorylationMalignant NeoplasmsPathway InteractionsIn VitroMolecularLeukemiaMutantReportingTumorAttenuatedBindingOncogenicRegulationAnabolismLinkMalignant Neoplasm Of Lung
Grant awards (42)
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras$398,657
R01 · FY2025 · CA · contact PI
Dietary trans-vaccenic acid enhances anti-tumor immunity$375,150
R01 · FY2025 · CA · contact PI
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras$378,725
R01 · FY2024 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$373,883
R01 · FY2024 · CA · contact PI
Dietary trans-vaccenic acid enhances anti-tumor immunity$356,393
R01 · FY2024 · CA · contact PI
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras$405,834
R01 · FY2023 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$385,639
R01 · FY2023 · CA · contact PI
Dietary trans-vaccenic acid enhances anti-tumor immunity$375,150
R01 · FY2023 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$15,541
R01 · FY2023 · CA · contact PI
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras$407,027
R01 · FY2022 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$386,416
R01 · FY2022 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$62,168
R01 · FY2022 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$408,334
R01 · FY2021 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK$47,578
R01 · FY2021 · CA · contact PI
Oxidative pentose phosphate pathway regulates AMPK homeostasis by balancing opposing LKB1 and PP2A$372,721
R01 · FY2020 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$205,078
R01 · FY2019 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$156,974
R01 · FY2019 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$50,123
R01 · FY2019 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$373,250
R01 · FY2018 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$325,412
R01 · FY2018 · CA · contact PI
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect$325,093
R01 · FY2018 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$373,250
R01 · FY2017 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$325,412
R01 · FY2017 · CA · contact PI
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect$325,093
R01 · FY2017 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$373,250
R01 · FY2016 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$325,412
R01 · FY2016 · CA · contact PI
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect$325,093
R01 · FY2016 · CA · contact PI
Metabolic rewiring by oncogenic BRAF V600E links ketogenesis pathway to BRAF-MEK1 signaling$387,250
R01 · FY2015 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$329,587
R01 · FY2015 · CA · contact PI
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect$325,093
R01 · FY2015 · CA · contact PI
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers$335,236
R01 · FY2014 · CA · contact PI
Mitochondrial acetyl-CoA acetyltransferase 1 promotes the Warburg effect$325,093
R01 · FY2014 · CA · contact PI
Tyrosine Kinase Signaling in Cancer Cell Metabolism$305,027
R01 · FY2014 · CA · contact PI
Tyrosine Kinase Signaling in Cancer Cell Metabolism$296,324
R01 · FY2013 · CA · contact PI
Tyrosine Kinase Signaling in Cancer Cell Metabolism$315,144
R01 · FY2012 · CA · contact PI
Tyrosine Kinase Signaling in Cancer Cell Metabolism$315,053
R01 · FY2011 · CA · contact PI
Tyrosine Kinase Signaling in Cancer Cell Metabolism$324,703
R01 · FY2010 · CA · contact PI
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome$263,700
R01 · FY2010 · CA · contact PI
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome$263,700
R01 · FY2009 · CA · contact PI
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome$263,700
R01 · FY2008 · CA · contact PI
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome$263,700
R01 · FY2007 · CA · contact PI
Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome$271,575
R01 · FY2006 · CA · contact PI